Trust in the Food and Drug Administration: A National Survey Study

Documenti analoghi

• Orphan Designation for Drugs Approved in the United States and European Union: A Comparative Analysis
  di: Enrico Costa, et al.
  Pubblicazione: (2026)
• How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians
  di: Ameet Sarpatwari, et al.
  Pubblicazione: (2024)
• Frequency and Nature of Generic “Design Around” of Brand‐Name Patents in the United States
  di: Janet Freilich, et al.
  Pubblicazione: (2025)
• Post‐Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing
  di: Ian T.T. Liu, et al.
  Pubblicazione: (2026)
• The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway
  di: Rajanikanth Madabushi, et al.
  Pubblicazione: (2024)